2018-2023 Global Lifestyle Drugs Consumption Market Report

October 2018 | 176 pages | ID: 2014B859E56EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Lifestyle Drugs market for 2018-2023.
Lifestyle drug is an term commonly applied to medications which treat non–life-threatening and non-painful conditions such as baldness, wrinkles, erectile dysfunction, or acne, which the speaker perceives as either not medical problems at all or as minor medical conditions relative to others. Proponents point out that improving the patient's subjective quality of life has always been a primary concern of medicine.
There is direct impact of lifestyle drugs on society, particularly in the developing world. Implications associated with labeling of indications and products sales of these lifestyle drugs may be varied. Drugs can, over time, switch from 'lifestyle' to 'mainstream' use.

Over the next five years, LPI(LP Information) projects that Lifestyle Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Lifestyle Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Depression
• Dermatology
• Sexual dysfunction
• Obesity

Segmentation by application:

• Children
• Adults
• Senior Citizens

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Allergan
• BMS
• Eli Lilly
• Pfizer
• Acerus Pharmaceuticals
• Alkermes
• Amorepacific
• AndroScience
• Anterios
• AstraZeneca
• Avanir Pharmaceuticals
• Avolynt
• Celtaxsys
• Cerecor
• Corcept Therapeutics
• Cosmo Pharmaceuticals
• CTC Bio
• Dermira
• Dong-A ST
• Euthymics Bioscience
• Foamix
• Follicum
• Forendo Pharma
• Futura Medical Developments
• Galderma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Lifestyle Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Lifestyle Drugs market by identifying its various subsegments.
• Focuses on the key global Lifestyle Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Lifestyle Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Lifestyle Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL LIFESTYLE DRUGS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lifestyle Drugs Consumption 2013-2023
  2.1.2 Lifestyle Drugs Consumption CAGR by Region
2.2 Lifestyle Drugs Segment by Type
  2.2.1 Depression
  2.2.2 Dermatology
  2.2.3 Sexual dysfunction
  2.2.4 Obesity
2.3 Lifestyle Drugs Consumption by Type
  2.3.1 Global Lifestyle Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Lifestyle Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Lifestyle Drugs Sale Price by Type (2013-2018)
2.4 Lifestyle Drugs Segment by Application
  2.4.1 Children
  2.4.2 Adults
  2.4.3 Senior Citizens
2.5 Lifestyle Drugs Consumption by Application
  2.5.1 Global Lifestyle Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Lifestyle Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Lifestyle Drugs Sale Price by Application (2013-2018)

3 GLOBAL LIFESTYLE DRUGS BY PLAYERS

3.1 Global Lifestyle Drugs Sales Market Share by Players
  3.1.1 Global Lifestyle Drugs Sales by Players (2016-2018)
  3.1.2 Global Lifestyle Drugs Sales Market Share by Players (2016-2018)
3.2 Global Lifestyle Drugs Revenue Market Share by Players
  3.2.1 Global Lifestyle Drugs Revenue by Players (2016-2018)
  3.2.2 Global Lifestyle Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Lifestyle Drugs Sale Price by Players
3.4 Global Lifestyle Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Lifestyle Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Lifestyle Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 LIFESTYLE DRUGS BY REGIONS

4.1 Lifestyle Drugs by Regions
  4.1.1 Global Lifestyle Drugs Consumption by Regions
  4.1.2 Global Lifestyle Drugs Value by Regions
4.2 Americas Lifestyle Drugs Consumption Growth
4.3 APAC Lifestyle Drugs Consumption Growth
4.4 Europe Lifestyle Drugs Consumption Growth
4.5 Middle East & Africa Lifestyle Drugs Consumption Growth

5 AMERICAS

5.1 Americas Lifestyle Drugs Consumption by Countries
  5.1.1 Americas Lifestyle Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Lifestyle Drugs Value by Countries (2013-2018)
5.2 Americas Lifestyle Drugs Consumption by Type
5.3 Americas Lifestyle Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Lifestyle Drugs Consumption by Countries
  6.1.1 APAC Lifestyle Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Lifestyle Drugs Value by Countries (2013-2018)
6.2 APAC Lifestyle Drugs Consumption by Type
6.3 APAC Lifestyle Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Lifestyle Drugs by Countries
  7.1.1 Europe Lifestyle Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Lifestyle Drugs Value by Countries (2013-2018)
7.2 Europe Lifestyle Drugs Consumption by Type
7.3 Europe Lifestyle Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lifestyle Drugs by Countries
  8.1.1 Middle East & Africa Lifestyle Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Lifestyle Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Lifestyle Drugs Consumption by Type
8.3 Middle East & Africa Lifestyle Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Lifestyle Drugs Distributors
10.3 Lifestyle Drugs Customer

11 GLOBAL LIFESTYLE DRUGS MARKET FORECAST

11.1 Global Lifestyle Drugs Consumption Forecast (2018-2023)
11.2 Global Lifestyle Drugs Forecast by Regions
  11.2.1 Global Lifestyle Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Lifestyle Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Lifestyle Drugs Forecast by Type
11.8 Global Lifestyle Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Allergan
  12.1.1 Company Details
  12.1.2 Lifestyle Drugs Product Offered
  12.1.3 Allergan Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Allergan News
12.2 BMS
  12.2.1 Company Details
  12.2.2 Lifestyle Drugs Product Offered
  12.2.3 BMS Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 BMS News
12.3 Eli Lilly
  12.3.1 Company Details
  12.3.2 Lifestyle Drugs Product Offered
  12.3.3 Eli Lilly Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Eli Lilly News
12.4 Pfizer
  12.4.1 Company Details
  12.4.2 Lifestyle Drugs Product Offered
  12.4.3 Pfizer Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Pfizer News
12.5 Acerus Pharmaceuticals
  12.5.1 Company Details
  12.5.2 Lifestyle Drugs Product Offered
  12.5.3 Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Acerus Pharmaceuticals News
12.6 Alkermes
  12.6.1 Company Details
  12.6.2 Lifestyle Drugs Product Offered
  12.6.3 Alkermes Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Alkermes News
12.7 Amorepacific
  12.7.1 Company Details
  12.7.2 Lifestyle Drugs Product Offered
  12.7.3 Amorepacific Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Amorepacific News
12.8 AndroScience
  12.8.1 Company Details
  12.8.2 Lifestyle Drugs Product Offered
  12.8.3 AndroScience Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 AndroScience News
12.9 Anterios
  12.9.1 Company Details
  12.9.2 Lifestyle Drugs Product Offered
  12.9.3 Anterios Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Anterios News
12.10 AstraZeneca
  12.10.1 Company Details
  12.10.2 Lifestyle Drugs Product Offered
  12.10.3 AstraZeneca Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 AstraZeneca News
12.11 Avanir Pharmaceuticals
12.12 Avolynt
12.13 Celtaxsys
12.14 Cerecor
12.15 Corcept Therapeutics
12.16 Cosmo Pharmaceuticals
12.17 CTC Bio
12.18 Dermira
12.19 Dong-A ST
12.20 Euthymics Bioscience
12.21 Foamix
12.22 Follicum
12.23 Forendo Pharma
12.24 Futura Medical Developments
12.25 Galderma

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Lifestyle Drugs
Table Product Specifications of Lifestyle Drugs
Figure Lifestyle Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Lifestyle Drugs Consumption Growth Rate 2013-2023 (K Units)
Figure Global Lifestyle Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Lifestyle Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Depression
Table Major Players of Depression
Figure Product Picture of Dermatology
Table Major Players of Dermatology
Figure Product Picture of Sexual dysfunction
Table Major Players of Sexual dysfunction
Figure Product Picture of Obesity
Table Major Players of Obesity
Table Global Consumption Sales by Type (2013-2018)
Table Global Lifestyle Drugs Consumption Market Share by Type (2013-2018)
Figure Global Lifestyle Drugs Consumption Market Share by Type (2013-2018)
Table Global Lifestyle Drugs Revenue by Type (2013-2018) ($ million)
Table Global Lifestyle Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Lifestyle Drugs Value Market Share by Type (2013-2018)
Table Global Lifestyle Drugs Sale Price by Type (2013-2018)
Figure Lifestyle Drugs Consumed in Children
Figure Global Lifestyle Drugs Market: Children (2013-2018) (K Units)
Figure Global Lifestyle Drugs Market: Children (2013-2018) ($ Millions)
Figure Global Children YoY Growth ($ Millions)
Figure Lifestyle Drugs Consumed in Adults
Figure Global Lifestyle Drugs Market: Adults (2013-2018) (K Units)
Figure Global Lifestyle Drugs Market: Adults (2013-2018) ($ Millions)
Figure Global Adults YoY Growth ($ Millions)
Figure Lifestyle Drugs Consumed in Senior Citizens
Figure Global Lifestyle Drugs Market: Senior Citizens (2013-2018) (K Units)
Figure Global Lifestyle Drugs Market: Senior Citizens (2013-2018) ($ Millions)
Figure Global Senior Citizens YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Lifestyle Drugs Consumption Market Share by Application (2013-2018)
Figure Global Lifestyle Drugs Consumption Market Share by Application (2013-2018)
Table Global Lifestyle Drugs Value by Application (2013-2018)
Table Global Lifestyle Drugs Value Market Share by Application (2013-2018)
Figure Global Lifestyle Drugs Value Market Share by Application (2013-2018)
Table Global Lifestyle Drugs Sale Price by Application (2013-2018)
Table Global Lifestyle Drugs Sales by Players (2016-2018) (K Units)
Table Global Lifestyle Drugs Sales Market Share by Players (2016-2018)
Figure Global Lifestyle Drugs Sales Market Share by Players in 2016
Figure Global Lifestyle Drugs Sales Market Share by Players in 2017
Table Global Lifestyle Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Lifestyle Drugs Revenue Market Share by Players (2016-2018)
Figure Global Lifestyle Drugs Revenue Market Share by Players in 2016
Figure Global Lifestyle Drugs Revenue Market Share by Players in 2017
Table Global Lifestyle Drugs Sale Price by Players (2016-2018)
Figure Global Lifestyle Drugs Sale Price by Players in 2017
Table Global Lifestyle Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Lifestyle Drugs Products Offered
Table Lifestyle Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Lifestyle Drugs Consumption by Regions 2013-2018 (K Units)
Table Global Lifestyle Drugs Consumption Market Share by Regions 2013-2018
Figure Global Lifestyle Drugs Consumption Market Share by Regions 2013-2018
Table Global Lifestyle Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Lifestyle Drugs Value Market Share by Regions 2013-2018
Figure Global Lifestyle Drugs Value Market Share by Regions 2013-2018
Figure Americas Lifestyle Drugs Consumption 2013-2018 (K Units)
Figure Americas Lifestyle Drugs Value 2013-2018 ($ Millions)
Figure APAC Lifestyle Drugs Consumption 2013-2018 (K Units)
Figure APAC Lifestyle Drugs Value 2013-2018 ($ Millions)
Figure Europe Lifestyle Drugs Consumption 2013-2018 (K Units)
Figure Europe Lifestyle Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Lifestyle Drugs Consumption 2013-2018 (K Units)
Figure Middle East & Africa Lifestyle Drugs Value 2013-2018 ($ Millions)
Table Americas Lifestyle Drugs Consumption by Countries (2013-2018) (K Units)
Table Americas Lifestyle Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Lifestyle Drugs Consumption Market Share by Countries in 2017
Table Americas Lifestyle Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Lifestyle Drugs Value Market Share by Countries (2013-2018)
Figure Americas Lifestyle Drugs Value Market Share by Countries in 2017
Table Americas Lifestyle Drugs Consumption by Type (2013-2018) (K Units)
Table Americas Lifestyle Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Lifestyle Drugs Consumption Market Share by Type in 2017
Table Americas Lifestyle Drugs Consumption by Application (2013-2018) (K Units)
Table Americas Lifestyle Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Lifestyle Drugs Consumption Market Share by Application in 2017
Figure United States Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure United States Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Canada Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Mexico Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Lifestyle Drugs Consumption by Countries (2013-2018) (K Units)
Table APAC Lifestyle Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Lifestyle Drugs Consumption Market Share by Countries in 2017
Table APAC Lifestyle Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Lifestyle Drugs Value Market Share by Countries (2013-2018)
Figure APAC Lifestyle Drugs Value Market Share by Countries in 2017
Table APAC Lifestyle Drugs Consumption by Type (2013-2018) (K Units)
Table APAC Lifestyle Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Lifestyle Drugs Consumption Market Share by Type in 2017
Table APAC Lifestyle Drugs Consumption by Application (2013-2018) (K Units)
Table APAC Lifestyle Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Lifestyle Drugs Consumption Market Share by Application in 2017
Figure China Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure China Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Japan Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Korea Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure India Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure India Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Australia Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Lifestyle Drugs Consumption by Countries (2013-2018) (K Units)
Table Europe Lifestyle Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Lifestyle Drugs Consumption Market Share by Countries in 2017
Table Europe Lifestyle Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Lifestyle Drugs Value Market Share by Countries (2013-2018)
Figure Europe Lifestyle Drugs Value Market Share by Countries in 2017
Table Europe Lifestyle Drugs Consumption by Type (2013-2018) (K Units)
Table Europe Lifestyle Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Lifestyle Drugs Consumption Market Share by Type in 2017
Table Europe Lifestyle Drugs Consumption by Application (2013-2018) (K Units)
Table Europe Lifestyle Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Lifestyle Drugs Consumption Market Share by Application in 2017
Figure Germany Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Germany Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure France Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure France Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure UK Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Italy Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Russia Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Spain Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Lifestyle Drugs Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Lifestyle Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Lifestyle Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Lifestyle Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Lifestyle Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Lifestyle Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Lifestyle Drugs Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Lifestyle Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Lifestyle Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Lifestyle Drugs Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Lifestyle Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Lifestyle Drugs Consumption Market Share by Application in 2017
Figure Egypt Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Egypt Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure South Africa Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Israel Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure Turkey Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Lifestyle Drugs Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Lifestyle Drugs Value Growth 2013-2018 ($ Millions)
Table Lifestyle Drugs Distributors List
Table Lifestyle Drugs Customer List
Figure Global Lifestyle Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Lifestyle Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Lifestyle Drugs Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Lifestyle Drugs Consumption Market Forecast by Regions
Table Global Lifestyle Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Lifestyle Drugs Value Market Share Forecast by Regions
Figure Americas Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Americas Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure APAC Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure APAC Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Europe Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Europe Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Middle East & Africa Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure United States Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure United States Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Canada Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Canada Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Mexico Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Mexico Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Brazil Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Brazil Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure China Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure China Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Japan Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Japan Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Korea Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Korea Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Southeast Asia Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure India Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure India Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Australia Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Australia Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Germany Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Germany Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure France Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure France Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure UK Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure UK Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Italy Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Italy Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Russia Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Russia Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Spain Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Spain Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Egypt Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Egypt Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure South Africa Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure South Africa Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Israel Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Israel Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure Turkey Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure Turkey Lifestyle Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Lifestyle Drugs Consumption 2018-2023 (K Units)
Figure GCC Countries Lifestyle Drugs Value 2018-2023 ($ Millions)
Table Global Lifestyle Drugs Consumption Forecast by Type (2018-2023) (K Units)
Table Global Lifestyle Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Lifestyle Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Lifestyle Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Lifestyle Drugs Consumption Forecast by Application (2018-2023) (K Units)
Table Global Lifestyle Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Lifestyle Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Lifestyle Drugs Value Market Share Forecast by Application (2018-2023)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Allergan Lifestyle Drugs Market Share (2016-2018)
Table BMS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BMS Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure BMS Lifestyle Drugs Market Share (2016-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly Lifestyle Drugs Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Lifestyle Drugs Market Share (2016-2018)
Table Acerus Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Acerus Pharmaceuticals Lifestyle Drugs Market Share (2016-2018)
Table Alkermes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alkermes Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Alkermes Lifestyle Drugs Market Share (2016-2018)
Table Amorepacific Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amorepacific Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amorepacific Lifestyle Drugs Market Share (2016-2018)
Table AndroScience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AndroScience Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AndroScience Lifestyle Drugs Market Share (2016-2018)
Table Anterios Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Anterios Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Anterios Lifestyle Drugs Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Lifestyle Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Lifestyle Drugs Market Share (2016-2018)
Table Avanir Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Avolynt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celtaxsys Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cerecor Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Corcept Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CTC Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dermira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dong-A ST Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Euthymics Bioscience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Foamix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Follicum Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Forendo Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Futura Medical Developments Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galderma Basic Information, Manufacturing Base, Sales Area and Its Competitors